Receive Dr. Aman's FREE teaching email every Monday! 
  • Award Winning
    For Medical Education

  • Over 10 Years
    of Teaching Experience

  • Interest-Free Payments
    Up to 3 instalments with PayPal

  • ExcellentTrustPilot

AKT2-170

A new oral anticoagulant drug is being trialled in patients with Deep Vein Thrombosis to see if there are less cases of intracerebral haemorrhage over 1 year compared with Rivaroxaban. 100 patients had the new drug and 5 of these patients had an intracerebral haemorrhage. A further 100 patients who were on Rivaroxaban over this timeframe had 1 patient from their cohort develop an intracerebral haemorrhage.

What is the risk ratio for the new drug?

Pay in 3 interest-free payments

Late fees may apply. Learn more

Join #aroraWeekly

Dr Aman’s free revision video direct to your inbox every Monday!

 

* indicates required
Please select

Arora Medical Education will use the information you provide on this form to be in touch with you and to provide teaching updates and information about our courses. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at aman@aroramedicaleducation.co.uk. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.

5% off as a thank you!

Use Coupon 'website5'

🙏 Our simple appreciation for you visiting today...

Dr Aman and Dr Pooja Arora :)

X